Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

Objective. To evaluate safety and efficacy of intravenous ferric carboxymaltose (FCM) versus standard medical care (SMC) for iron-deficiency anemia (IDA) in postpartum women and women with heavy menstrual bleeding. Study Design. This open-label, multicenter study randomized women with IDA (hemoglobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seid, Melvin H., Butcher, Angelia D., Chatwani, Ashwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406716/
https://www.ncbi.nlm.nih.gov/pubmed/28487769
http://dx.doi.org/10.1155/2017/9642027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406716/
https://www.ncbi.nlm.nih.gov/pubmed/28487769
http://dx.doi.org/10.1155/2017/9642027

Ejemplares similares